Featured

Génome Québec invests up to $500,000 to boost RNA therapeutics innovation in Quebec

02.10.2024

Génome Québec invests up to $500,000 to boost RNA therapeutics innovation in Quebec

Montreal – October 2, 2024 – Génome Québec, a private, non-profit organization dedicated to advancing genomics research and innovation in Quebec, is investing up to $500,000 in McGill University’s D2R Initiative. This investment will advance the commercialization of innovative genomic technologies in Quebec through D2R’s Commercialization Priming funding program.  D2R’s(...)

Read more